Life Science REIT PLC

LABS:LSE

Life Science REIT PLC

Actions
  • Price (GBX)42.70
  • Today's Change0.10 / 0.23%
  • Shares traded121.77k
  • 1 Year change+22.70%
  • Beta-0.1494
Data delayed at least 20 minutes, as of Feb 20 2026 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2025202520242023
ASSETS
Cash And Short Term Investments145.5714
Total Receivables, Net6.663.054.25
Total Inventory------
Prepaid expenses--0.962.23
Other current assets, total02.560.17
Total current assets211221
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments382385382
Note receivable - long term3.413.833.41
Other long term assets4.0004.00
Total assets411401411
LIABILITIES
Accounts payable------
Accrued expenses--1.811.82
Notes payable/short-term debt--00
Current portion long-term debt/capital leases000
Other current liabilities, total--4.223.69
Total current liabilities--1214
Total long term debt--122108
Total debt108122108
Deferred income tax------
Minority interest------
Other liabilities, total--3.834.60
Total liabilities127138127
SHAREHOLDERS EQUITY
Common stock3.503.503.50
Additional paid-in capital------
Retained earnings (accumulated deficit)280259280
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity284263284
Total liabilities & shareholders' equity--401411
Total common shares outstanding350350350
Treasury shares - common primary issue--00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.